Hepatic Steatosis, Rather Than Underlying Obesity, Increases the Risk of Infection and Hospitalization for COVID-19
Adriana Roca‐Fernández(Hammersmith Hospital), Arun J. Sanyal(Virginia Commonwealth University), Andrea Dennis(Oxford Brookes University), Amitava Banerjee(University College London), John McGonigle(Imperial College London), Rajarshi Banerjee(John Radcliffe Hospital), Rowan C. Nicholls
Cited by 26
Related Papers
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
|Hepatology|2017|7.2k
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
|New England Journal of Medicine|2010|3.3k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k